Literature DB >> 20581214

Effect of celecoxib combined with thoracic epidural analgesia on pain after thoracotomy.

M Senard1, E P Deflandre, D Ledoux, L Roediger, B M Hubert, M Radermecker, D Libbrecht, J L Joris.   

Abstract

BACKGROUND: Thoracotomy results in severe postoperative pain potentially leading to chronic pain. We investigated the potential benefits of oral celecoxib on postoperative analgesia combined with thoracic epidural analgesia (TEA).
METHODS: Forty patients undergoing thoracotomy were included in this prospective, randomized, double-blind, placebo-controlled study. General anaesthesia was standardized. Patient-controlled epidural analgesia (T4-T5) was used during 48 h after surgery (ropivacaine 2 mg ml(-1) with sufentanil 0.5 microg ml(-1)). Patients were allocated to receive oral celecoxib or placebo from the evening before surgery until 48 h after operation. Postoperative pain scores, respiratory function, and morbidity were compared between the two groups.
RESULTS: Postoperative pain scores at rest (P=0.026) and during coughing (P=0.021) were lower and patient satisfaction was greater (P=0.0033) in the celecoxib group. Consumption of the local anaesthetic solution was comparable between groups. Postoperative restrictive pulmonary syndrome and morbidity were comparable between groups.
CONCLUSIONS: Celecoxib improves postoperative analgesia provided by TEA after thoracotomy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20581214     DOI: 10.1093/bja/aeq129

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  8 in total

1.  Use of ketorolac is associated with decreased pneumonia following rib fractures.

Authors:  Yifan Yang; Jason B Young; Carol R Schermer; Garth H Utter
Journal:  Am J Surg       Date:  2013-10-07       Impact factor: 2.565

2.  [Unexpected hemorrhage complications in association with celecoxib. Spontaneously reported case series after perioperative pain treatment in gynecological operations].

Authors:  T Stammschulte; K Brune; A Brack; H Augenstein; G Arends; U Gundert-Remy
Journal:  Anaesthesist       Date:  2014-12       Impact factor: 1.041

Review 3.  Postoperative pain management.

Authors:  Alexandros Kolettas; George Lazaridis; Sofia Baka; Ioannis Mpoukovinas; Vasilis Karavasilis; Ioannis Kioumis; Georgia Pitsiou; Antonis Papaiwannou; Sofia Lampaki; Anastasia Karavergou; Athanasia Pataka; Nikolaos Machairiotis; Nikolaos Katsikogiannis; Andreas Mpakas; Kosmas Tsakiridis; Nikolaos Fassiadis; Konstantinos Zarogoulidis; Paul Zarogoulidis
Journal:  J Thorac Dis       Date:  2015-02       Impact factor: 2.895

Review 4.  Regional anesthesia and acute perioperative pain management in thoracic surgery: a narrative review.

Authors:  Casey Hamilton; Paul Alfille; Jeremi Mountjoy; Xiaodong Bao
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

5.  Preemptive multimodal analgesia facilitates same-day discharge following robot-assisted hysterectomy.

Authors:  Thomas M Shultz
Journal:  J Robot Surg       Date:  2011-05-28

6.  Preoperative dexamethasone for acute post-thoracotomy analgesia: a randomized, double-blind, placebo-controlled study.

Authors:  Kyoung-Woon Joung; Hyeong Ryul Kim; Wook-Jong Kim; Ye Ji Lim; Jae Won Kim; Eun-Ho Lee; In-Cheol Choi
Journal:  BMC Anesthesiol       Date:  2018-09-27       Impact factor: 2.217

7.  Chronic postthoracotomy pain in transapical transcatheter aortic valve replacement.

Authors:  Brian R Gebhardt; Ankit Jain; Sarah A Basaham; Farhad Zahedi; Stefan Ianchulev; Larry H Brinckerhoff; John G Augoustides; Prakash A Patel; Andrea Tsai; Frederick C Cobey
Journal:  Ann Card Anaesth       Date:  2019 Jul-Sep

8.  Effect of Parecoxib as an Adjunct to Patient-Controlled Epidural Analgesia after Abdominal Hysterectomy: A Multicenter, Randomized, Placebo-Controlled Trial.

Authors:  Wei-Feng Liu; Hai-Hua Shu; Guo-Dong Zhao; Shu-Ling Peng; Jin-Fang Xiao; Guan-Rong Zhang; Ke-Xuan Liu; Wen-Qi Huang
Journal:  PLoS One       Date:  2016-09-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.